Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding messenger RNAs: Peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons

Neuroscience

Volumn 93, Issue 1, 1999, Pages 361-370

  McCarson, K E ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Formalin test; Inflammation; Neurokinin B; Primary afferent sensory neuron; Tachykinin

Indexed keywords

FORMALDEHYDE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ 3 RECEPTOR; SUBSTANCE P; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HYBRIDIZATION; INFLAMMATION; LIGAND BINDING; MALE; NOCICEPTION; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; SENSORY NERVE CELL; TARGET ORGAN;

ANIMALS; CENTRAL NERVOUS SYSTEM; FORMALDEHYDE; IN SITU HYBRIDIZATION; MALE; NEURITIS; NEURONS, AFFERENT; PERIPHERAL NERVOUS SYSTEM; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-3; RIBONUCLEASES; RNA PROBES; RNA, MESSENGER; SUBSTANCE P; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC;

EID: 0033040501     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00102-5     Document Type: Article

References (72)

1. Ahluwalia A., Giuliani S., Maggi C.A. Demonstration of a "septide-sensitive" inflammatory response in rat skin. Br. J. Pharmac. 116:1995;2170-2174.
2. Andoh T., Nagasawa T., Kuraishi Y. Expression of tachykinin NK1 receptor mRNA in dorsal root ganglia of the mouse. Molec. Brain Res. 35:1996;329-332.
3. Ansel J.C., Kaynard A.H., Armstrong C.A., Olerud J., Bunnett N., Payan D. Skin-nervous system interactions. J. invest. Dermatol. 106:1996;198-204.
4. Barber R.P., Vaughn J.E., Slemmon J.R., Salvattera P.M., Roberts E., Leeman S.E. The origin, distribution, and synaptic relationships of substance P axons in rat spinal cord. J. comp. Neurol. 184:1979;331-352.
5. Brown J.L., Liu H., Maggio J.E., Vigna S.R., Mantyh P.W., Basbaum A.I. Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J. comp. Neurol. 356:1995;327-344.
6. Carlton S.M., Zhou S., Coggeshall R.E. Localization and activation of substance P receptors in unmyelinated axons of rat glabrous skin. Brain Res. 734:1996;103-108.
7. Carlton S.M., Coggeshall R.E. Nocicpetive integration: does it have a peripheral component? Pain Forum. 7:1998;71-78.
8. Carter M.S., Krause J.E. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide g. J. Neurosci. 10:1990;2203-2214.
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analyt. Biochem. 162:1987;156-159.
10. Cohen R.H., Perl E.R. Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors. J. Neurophysiol. 64:1990;457-464.
11. 125I] Bolton-Hunter substance P binding sites in human and rat skin. Neurosci. Lett. 99:1989;287-292.
12. DeKoninck Y., Ribeiro-da-Silva A., Henry J.L., Cuello C. Spinal neurons exhibiting a specific nociceptive response receive abundant substance P-containing synaptic contacts. Proc. natn. Acad. Sci. U.S.A. 89:1992;5073-5077.
13. de Souza B.N., Horrocks L.A. Development of rat spinal cord I. weight and length with a method for rapid removal. Devl Neurosci. 2:1979;115-121.
14. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
15. B receptor agonists. Life Sci. 62:1998;1525-1530.
16. Go V.W., Yaksh T.L. Release of substance P from the cat spinal cord. J. Physiol. 391:1987;141-167.
17. Hagermark O., Hokfelt T., Pernow B. Flare and itch induced by substance P in human skin. J. invest. Dermatol. 71:1978;233-235.
18. Harmar A., Keen P. Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro. Brain Res. 231:1982;379-385.
19. Helke C.J., Krause J.E., Mantyh P.W., Couture R., Bannon M.J. Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms. Fedn Am. Socs exp. Biol. J. 4:1990;1606-1615.
20. Helme R.D., Koschorke G.M., Zimmerman M. Immunoreactive substance P release from skin nerves in the rat by noxious thermal stimulation. Neurosci. Lett. 63:1986;295-299.
21. Henry J.L. Effects of substance P on functionally identified units in cat spinal cord. Brain Res. 114:1976;439-451.
22. Heppelman B., Pawlak M. Sensitization of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci. Lett. 223:1997;97-100.
23. Hershey A.D., Krause J.E. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science. 247:1990;958-962.
24. Hershey A.D., Dykema P.E., Krause J.E. Organization, structure, and expression of the gene encoding the rat substance P receptor. J. biol. Chem. 266:1991;4366-4374.
25. Hökfelt T., Kellerth J.O., Nilsson G., Pernow B. Experimental immunohistochemical studies on the location and distribution of substance P in cat primary sensory neurons. Brain Res. 100:1975;235-252.
26. Hong Y., Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience. 63:1994;827-836.
27. Jacques L., Couture R., Drapeau G., Regoli D. Capillary permeability induced by intravenous neurokinins. Naunyn-Schmiedeberg's Arch. Pharmac. 340:1989;170-179.
28. 125I-substance P on neurones from cultured rat superior cervical ganglion. Brain Res. 458:1988;205-211.
29. Jessell T., Tsunoo A., Kanazawa I., Otsuka M. Substance P: depletion in the dorsal horn of rat spinal cord after section of the peripheral processes of primary sensory neurons. Brain Res. 168:1979;247-259.
30. Konishi S., Song S.Y., Ogawa T., Kanazawa I. Fast and slow depolarizations produced by substance P and other tachykinins in sympathetic neurons of rat prevertebral ganglia. Neurosci. Res. 14:1992;81-95.
31. Krause J.E., Cremins J.D., Carter M.S., Brown E.R., MacDonald M.R. Solution hybridization-nuclease protection assays for sensitive detection of differentially spliced substance P- and neurokinin A-encoding messenger ribonucleic acids. Meth. Enzym. 168:1989;634-652.
32. Kress M. and Reeh P. W. (1996) Chemical excitation and sensitization in nociceptors. In Neurobiology of Nociceptors (eds Belmonte C. and Cervero F.), p. 245. Oxford University Press, New York.
33. Kumazawa T., Mizumura K. Effects of synthetic substance P on unit-discharges of testicular nociceptors of dogs. Brain Res. 170:1979;553-557.
34. Laneuville O., Dorais J., Couture R. Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. Life Sci. 42:1988;1295-1305.
35. Lembeck F., Gamse R. Lack of algesic effect of substance P on paravascular pain receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 299:1977;295-303.
36. Lembeck F., Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch. Pharmac. 310:1979;175-183.
37. Mantyh P.W., Hunt S.P. The autoradiographic localization of substance P receptors in the rat and bovine spinal cord and the cat spinal trigeminal nucleus pars caudalis and the effects of neonatal capsaicin. Brain Res. 332:1985;315-324.
38. Mantyh P.W., Gates T., Mantyh C.R., Maggio J.E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J. Neurosci. 9:1989;258-279.
39. Mantyh P.W., Catton M.D., Allen C.J., Labenski M.E., Maggio J.E., Vigna S.R. Receptor binding sites for cholecystokinin, galanin, somatostatin, substance P and vasoactive intestinal polypeptide in sympathetic ganglia. Neuroscience. 46:1992;739-754.
40. McCarson K.E., Goldstein B.D. Naloxone blocks the formalin-induced increase of substance P in the dorsal horn. Pain. 38:1989;339-345.
41. McCarson K.E., Goldstein B.D. Timecourse of the alteration in substance P levels in the dorsal horn following formalin: blockade by naloxone. Pain. 41:1990;95-100.
42. McCarson K.E., Goldstein B.D. Release of substance P into the superficial dorsal horn following nociceptive activation of the hind paw of the rat. Brain Res. 568:1991;105-116.
43. McCarson K.E., Krause J.E. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci. 14:1994;712-720.
44. McCarson K.E., Krause J.E. The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration. Neuroscience. 64:1995;729-739.
45. McCarson K.E., Krause J.E. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression. Molec. Pharmac. 50:1996;1189-1199.
46. B receptor activation and neurokinin receptor expression in spinal cord. Pharmac. Rev. Commun. 8:1996;191-194.
47. Mizumura K., Sato J., Kumazawa T. Effects of prostaglandins and other putative chemical intermediaries on the activity of canine testicular polymodal receptors studied in vitro. Pflügers Arch. 408:1987;565-572.
48. Moussaoui S.M., Hermans E., Mathieu A.M., Bonici B., Clerc F., Guinet F., Garret C., Laduron P.M. Polyclonal antibodies against the rat NK1 receptor: characterization and localization in the spinal cord. NeuroReport. 3:1992;1073-1076.
49. Nagahisa A., Kanai Y., Suga O., Taniguchi K., Tsuchiya M., Lowe J.A., Hess H.J. Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist. Eur. J. Pharmac. 217:1992;191-195.
50. Nakamura-Craig M., Smith T.W. Substance P and peripheral inflammatory hyperalgesia. Pain. 38:1989;91-98.
51. O'Flynn N.M., Helme R.D., Watkins D.J., Burcher E. Autoradiographic localization of substance P binding sites in rat foot-pad skin. Neurosci. Lett. 106:1989;43-48.
52. Ogawa T., Kanazawa I., Kimura S. Regional distribution of substance P, neurokinin α and neurokinin β in rat spinal cord, nerve roots and dorsal root ganglia, and the effects of dorsal root section or spinal transection. Brain Res. 359:1985;152-157.
53. Piercey M.F., Dobry P.J.K., Schroeder L.A., Einspahr F.J. Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res. 210:1981;407-412.
54. Pincelli C., Fantini F., Giardino L., Zanni M., Calza L., Sevignani C., Giannetti A. Autoradiographic detection of substance P receptors in normal and psoriatic skin. J. invest. Dermatol. 101:1993;301-304.
55. Radhakrishnan V., Henry J.L. Novel substance P antagonist, CP-96,345, blocks responses of cat spinal neurons to noxious cutaneous stimulation and to substance P. Neurosci. Lett. 132:1991;39-43.
56. Ruocco I., Krause J.E., Ribiero-da-Silva A. Anatomical localization of substance P and the neurokinin-1 receptor in the skin of the rat lower lip: an electron microscopy study. Neurosci. Abstr. 23:1997;1490.
57. Rogers S.D., Van Erem A.L., Ghilardi J.R., Vigna S.R., Mantyh P.W. Confocal imaging of substance P (NK-1) receptor expression in the normal, nerve injured and inflamed skin. Neurosci. Abstr. 22:1996;1804.
58. Sakurada T., Katsumata K., Yogo H., Tan-No K., Sakurada S., Kisara K. Antinociception induced by CP96,345, a non-peptide NK-1 receptor antagonist, in the mouse formalin and capsaicin tests. Neurosci. Lett. 151:1993;142-145.
59. Seabrook G.R., Main M., Bowery B., Wood N., Hill R.G. Differences in neurokinin receptor pharmacology between rat and guinea-pig superior cervical ganglia. Br. J. Pharmac. 105:1992;925-928.
60. Seguin L., Millan M.J. The glycine B receptor agonist, (+)-HA966, enhances induction of antinociception by RP67580 and CP-99,994. Eur. J. Pharmac. 253:1994;R1-R3.
61. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J. biol. Chem. 265:1990;623-628.
62. Tjolsen A., Berge O.-G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
63. Toda T., Hayashi H. The inhibitory effect of substance P antagonist, CP-96,345, on the late discharges of nociceptive neurons in the rat superficial spinal dorsal horn. Neurosci. Lett. 158:1993;36-38.
64. Tsuchida K., Shigemoto R., Yokota Y., Nakanishi S. Tissue distribution and quantitation of the mRNAs for three rat tachykinin receptors. Eur. J. Biochem. 193:1990;751-757.
65. Warden M.K., Young W.S. Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J. comp. Neurol. 272:1988;90-113.
66. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agents. Pain. 40:1990;229-238.
67. White D.M., Helme R.D. Release of substance P from peripheral nerve terminals following electrical stimulation of the sciatic nerve. Brain Res. 336:1985;27-31.
68. Yaksh T.L., Jessell T.M., Gamse R., Mudge A.W., Leeman S.E. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature. 286:1980;455-457.
69. Yamamoto Y., Yaksh T.L. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci. 49:1991;1955-1963.
70. Yashpal K., Dam T.V., Quirion R. Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord. Brain Res. 506:1990;259-266.
71. Yashpal K., Radhakrishnan V., Coderre T.J., Henry J.L. CP-96,345, but not its stereoisomer, CP-96344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience. 52:1993;1039-1047.
72. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H., Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J. biol. Chem. 264:1989;17,649-17,652.